Early cytokine dysregulation and viral replication are associated with mortality during lethal influenza infection

Viral Immunology

Volumn 27, Issue 5, 2014, Pages 214-224

  Vogel, Alexander J ^a,b   Harris, Seth ^b   Marsteller, Nathan ^a   Condon, Shirley A ^a,b   Brown, Deborah M ^a,b  

^a UNIVERSITY OF NEBRASKA   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; CXCL9 CHEMOKINE; CYTOKINE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OSELTAMIVIR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FATALITY; HISTOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOREGULATION; INFLAMMATION; INFLUENZA A; INFLUENZA A VIRUS (A/PUERTO RICO/8/1934(H1N1)); INTERFERON PRODUCTION; LD 50; LETHALITY; MORBIDITY; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; VIRUS REPLICATION; VIRUS TITRATION; ANIMAL; BAGG ALBINO MOUSE; CYTOCHEMISTRY; DISEASE MODEL; IMMUNOLOGY; INFLUENZA VIRUS A; LUNG; MALE; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SURVIVAL; VIROLOGY; VIRUS LOAD;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HISTOCYTOCHEMISTRY; INFLUENZA A VIRUS; LUNG; MALE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84902012250     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2013.0095     Document Type: Article

References (46)

1. Bradley-Stewart A, Jolly L, Adamson W, et al. Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09. J Clin Virol 2013;58:100-107.
2. Brown DM, Dilzer AM, Meents DL, and Swain SL. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol 2006;177:2888-2898.
3. Brown DM, Lee S, Garcia-Hernandez Mde L, and Swain SL. Multifunctional CD4 cells expressing gamma inter-feron and perforin mediate protection against lethal influenza virus infection. J Virol 2012;86:6792-6803.
4. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005;6:135.
5. Crouser ED, Shao G, Julian MW, et al. Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Crit Care Med 2009; 37: 2000-2009.
6. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-1207.
7. Dienz O, Rud JG, Eaton SM, et al. Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutro-phil survival in the lung. Mucosal Immunol 2012;5:258-266.
8. Ding Z, Liu S, Wang X, et al. Oxidant stress in mito-chondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep 2013;3:1077.
9. Dybing JK, Schultz-Cherry S, Swayne DE, et al. Distinct pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol 2000;74:1443-1450.
10. Fujisawa H. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol 2008;82:2772-2783.
11. Govorkova EA, Leneva IA, Goloubeva OG, et al. Comparison of efficacies of RWJ-270201, zanamivir, and oseltami-vir against H5N1, H9N2, and other avian influenza viruses. Antimicrob Agents Chemother 2001;45:2723-2732.
12. Harty JT, Tvinnereim AR, and White DW. CD8 + T cell effector mechanisms in resistance to infection. Annu Rev Immunol 2000;18:275-308.
13. Hensley SE, Das SR, Bailey AL, et al. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 2009;326:734-736.
14. Iwasaki A and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-995.
15. Kash JC, Tumpey TM, Proll SC, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006;443:578-581.
16. Kato H, Sato S, Yoneyama M, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005;23:19-28.
17. Kobasa D, Jones SM, Shinya K, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007;445:319-323.
18. Kozak W, Conn CA, Klir JJ, et al. TNF soluble receptor and antiserum against TNF enhance lipopolysaccharide fever in mice. Am J Physiol 1995;269:R23-29.
19. La Gruta NL, Kedzierska K, Stambas J, and Doherty PC. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007;85:85-92.
20. Lee CW, Senne DA, Suarez DL. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 2004;78:8372-8381.
21. Lee LY, Ha do LA, Simmons C, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008;118:3478-3490.
22. Le Goffic R, Pothlichet J, Vitour D, et al. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 2007;178:3368-3372.
23. Lund JM, Alexopoulou L, Sato A, et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 2004;101:5598-5603.
24. McAuley JL, Hornung F, Boyd KL, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2007;2:240-249.
25. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006;6:173-182.
26. Peiris JS, Hui KP, Yen HL. Host response to influenza virus: protection versus immunopathology. Curr Opin Immunol 2010;22:475-481.
27. Rehwinkel J, Tan CP, Goubau D, et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010;140:397-408.
28. Rimmelzwaan GF, Kuiken T, van Amerongen G, et al. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 2001;75:6687-6691.
29. Rincon M. Interleukin-6: from an inflammatory marker to a target for inflammatory diseases. Trends Immunol 2012;33: 571-577.
30. Rutigliano JA, Sharma S, Morris MY, et al. Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells. J Virol 2014;88:1636-1651.
31. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 2007;104: 12479-12481.
32. Sanders CJ, Doherty PC, Thomas PG. Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res 2011;343:13-21.
33. Snelgrove RJ, Godlee A, and Hussell T. Airway immune homeostasis and implications for influenza-induced inflammation. Trends Immunol 2011;32:328-334.
34. Szretter KJ, Gangappa S, Lu X, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007;81:2736-2744.
35. Tate MD, Ioannidis LJ, Croker B, et al. The role of neu-trophils during mild and severe influenza virus infections of mice. PLoS One 2011;6:e17618.
36. Tate MD, Schilter HC, Brooks AG, and Reading PC. Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus. Viral Immunol 2011;24:77-88.
37. Taubenberger JK, and Morens DM. The pathology of influenza virus infections. Annu Rev Pathol 2008;3:499-522.
38. Thomas PG, Keating R, Hulse-Post DJ, and Doherty PC. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006;12:48-54.
39. Treanor J. Influenza vaccine-outmaneuvering antigenic shift and drift. New Engl J Med 2004;350:218-220.
40. Tumpey TM, Garcia-Sastre A, Taubenberger JK, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005;79:14933-14944.
41. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet Microbiol 2000;74:109-116.
42. Wong P, and Pamer EG. CD8 T cell responses to infectious pathogens. Annu Rev Immunol 2003;21:29-70.
43. Xu L, Yoon H, Zhao MQ, et al. Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J Immunol 2004; 173:721-725.
44. Xu T, Qiao J, Zhao L, et al. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Crit Care Med 2006;174:1011-1017.
45. Zhang Q, Itagaki K, Hauser CJ. Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock 2010;34:55-59.
46. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochon-drial DAMPs cause inflammatory responses to injury. Nature 2010;464:104-107.